ARCHIVES

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

NCI-Approved Clinical Trials

November 24, 2006

In Brief: Murphy To Head Pediatric Oncology Group; DeVita To Receive ACCC Research Award

May 1, 1992

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.

July 28, 2000

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993